A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study of Amlodipine and Losartan Versus Two Co-administration of Amlodipine and Losartan in Healthy Caucasian Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2011
At a glance
- Drugs Amlodipine; Amlodipine/losartan; Losartan
- Indications Angina pectoris; Diabetic nephropathies; Heart failure; Hypertension
- Focus Pharmacokinetics
- 26 Apr 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 10 Jan 2011 Hanmi Pharmaceuticals is planning to submit application for marketing approval of Amosartan in European countries in late 2011, according to a company media release.
- 10 Jan 2011 Status changed from recruiting to completed, according to a Hanmi Pharmaceuticals media release.